Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: A potential new therapeutic approach

Article

Abstract: Background: Approximately 30% of breast tumors do not express the estrogen receptor (ER) α, which is

Palabras claves:

Breast Cancer, Calcitriol, Estrogen receptor, Hormonal therapy, VDR

Autores:

Avila-Chávez E., David B., Díaz L., Esparza-López J., García-Becerra R., García-Quiroz J., Halhali A., Ibarra-Sánchez M., Javier Camacho, Larrea F., Medina-Franco H., Ordaz-Rosado D., Santos-Martínez N.

Fuentes:

scopus